UnitedHealth Group Incorporated (UNH) Stock Analysis
A live, multi-source view of UnitedHealth Group Incorporated (UNH): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management.
Sector: Healthcare · Industry: Healthcare Plans · United States · 390,000 employees · unitedhealthgroup.com
Key statistics · as of 2026-09-05
As of 2026-09-05, UnitedHealth Group Incorporated (UNH) had a market capitalization of $356.47B, a trailing P/E of 25.8 (forward 17.7), a dividend yield of 2.31% and a beta of 0.62; the shares traded in a 52-week range of $255.97 – $461.62 (25.2% over the year).
- Market cap
- $356.47B
- Enterprise value
- $405.83B
- Trailing P/E
- 25.8
- Forward P/E
- 17.7
- PEG ratio
- 1.09
- Price / book
- 3.65
- EPS (trailing)
- $15.41
- EPS (forward)
- $22.44
- Dividend yield
- 2.31%
- Payout ratio
- 57.5%
- Ex-dividend date
- 2026-09-14
- 52-week range
- $255.97 – $461.62
- 52-week change
- 25.2%
- Beta
- 0.62
- Average volume
- 5.3M
- Shares outstanding
- 897.6M
- Short % of float
- 1.92%
- Profit margin
- 3.1%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, UnitedHealth Group Incorporated (UNH) last closed at $388.28 (the last completed close before that scan).
Technicals at the scan: RSI 41 (neutral territory), price -1.8% versus its 20-day average, 20-day versus 50-day average spread -3.6%, MACD histogram 0.40.
Sentiment inputs: 69% of recent Finnhub-scored headlines read bullish; StockTwits 71% bullish; Reddit mentions 0% over 24 hours; analyst consensus score 78/100.
Next scheduled company event: in 11 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 3 buys and 5 sells of UNH; corporate insiders filed 0 buys and 2 sells (6 distinct filers, latest disclosure 2026-08-25). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Richard McCormick (0B/3S), Patrick Hugh Conway (0B/2S), John Boozman (2B/0S), Alan Armstrong (1B/0S), Dan Newhouse (0B/1S), Maria Elvira Salazar (0B/1S). Who is trading what
RapidTradeView pick record
UNH has been a daily pick 1 time; 0 of 1 graded picks beat SPY over the following five trading days. Most recent: 2026-07-29, rank #2, -7.39% versus SPY (lagged). Full scoreboard
What this page covers
RapidTradeView pulls UnitedHealth Group Incorporated (UNH) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell UNH.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.